EU needs tiered drug pricing to improve patient access: Bayer exec Ruchika Sharma6 May 2023 9:00 AM ISTBoston: The European Union should put mechanisms in place to allow drugmakers to charge higher prices in wealthy European countries and lower...
Bayer investors re-elect Norbert Winkeljohann as board chairman Ruchika Sharma1 May 2023 11:23 AM ISTFrankfurt: Bayer Chairman Norbert Winkeljohann on Friday comfortably won a re-election vote at the drugmaker's annual shareholder meeting with an...
Bayer Chairman Norbert Winkeljohann wins backing from major shareholder advisory firms Ruchika Sharma16 April 2023 1:00 PM ISTFrankfurt: Bayer Chairman Norbert Winkeljohann has won backing for his re-election from a pair of major shareholder advisory firms despite criticism...
Bayer establishes Bioethics Council Ruchika Sharma5 April 2023 12:22 PM ISTLeverkusen: Bayer AG has established a Bioethics Council consisting of internationally renowned experts, to provide broad independent perspective...
Bayer defeats Merck in lawsuit over talc liabilities Ruchika Sharma4 April 2023 3:00 PM IST"Bayer will continue to defend itself against any further efforts by Merck to avoid or improperly transfer its liabilities to Bayer," the company said...
Bayer to shift drug research focus away from women's health Ruchika Sharma26 March 2023 12:00 PM ISTBayer, which acquired a large women's health business under the 2006 takeover of Schering Pharma, will focus drugs research on oncology,...
Bayer gets EU approval for Nubeqa for additional indication in prostate cancer Ruchika Sharma5 March 2023 1:00 PM ISTNubeqa is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Bayer concludes acquisition of Blackford Analysis Ruchika Sharma16 Feb 2023 10:00 AM ISTBerlin: Bayer has announced that the company has completed the acquisition of the global strategic imaging AI platform and solutions provider...
Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, type 2 diabetes Ruchika Sharma12 Feb 2023 3:41 PM ISTKerendia is a non-steroidal, selective mineralocorticoid receptor (MR) antagonist that has been shown to block harmful effects of MR overactivation.
Former Roche Executive Bill Anderson to become new CEO of Bayer Ruchika Sharma9 Feb 2023 4:15 PM ISTLeverkusen: Bill Anderson will become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1,...
Bayer submits Aflibercept 8 mg for regulatory approval in two major retinal eye diseases in EU Ruchika Sharma7 Feb 2023 2:15 PM ISTAflibercept 8 mg is being jointly developed by Bayer and Regeneron.
Bayer under investor pressure to speed up CEO changeover Ruchika Sharma2 Feb 2023 4:15 PM ISTBaumann, who engineered the troubled Monsanto deal, was given a new contract in 2020 that runs until 2024 and said at the time he would leave the...
